BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25129079)

  • 1. [NCCN Asian consensus statement - can Asian patients with cancer accept treatment modalities from NCCN guidelines ?].
    Ozono S; Hinotsu S; Namiki M; Akaza H
    Gan To Kagaku Ryoho; 2014 Jun; 41(6):683-6. PubMed ID: 25129079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is the Asian Consensus Statement on NCCN clinical practice guidelines in oncology (NCCN-ACS)?
    Akaza H
    Jpn J Clin Oncol; 2016 Apr; 46(4):299-302. PubMed ID: 26830151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asia Consensus Statement on NCCN Clinical Practice Guideline for bladder cancer.
    Nishiyama H
    Jpn J Clin Oncol; 2018 Jan; 48(1):3-6. PubMed ID: 29145591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NCCN Asia Consensus Statement prostate cancer.
    Hinotsu S; Namiki M; Ozono S; Akaza H
    Jpn J Clin Oncol; 2018 Nov; 48(11):964-965. PubMed ID: 30184146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NCCN Guidelines Development Program.
    Winn RJ; Botnick W; Dozier N
    Oncology (Williston Park); 1996 Nov; 10(11 Suppl):23-8. PubMed ID: 8953592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NCCN and ACS collaborate on a patient's version of the NCCN practice guidelines for breast cancer. National Comprehensive Cancer Network. American Cancer Society.
    Rose VL
    Am Fam Physician; 1999 Nov; 60(7):2169-70. PubMed ID: 10569514
    [No Abstract]   [Full Text] [Related]  

  • 7. Consensus recommendations for management of head and neck cancer in Asian countries: a review of international guidelines.
    D'cruz A; Lin T; Anand AK; Atmakusuma D; Calaguas MJ; Chitapanarux I; Cho BC; Goh BC; Guo Y; Hsieh WS; Hu C; Kwong D; Lin JC; Lou PJ; Lu T; Prabhash K; Sriuranpong V; Tang P; Vu VV; Wahid I; Ang KK; Chan AT
    Oral Oncol; 2013 Sep; 49(9):872-877. PubMed ID: 23830839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a prostate multidisciplinary clinic program on patient treatment decisions and on adherence to NCCN guidelines: the William Beaumont Hospital experience.
    Korman H; Lanni T; Shah C; Parslow J; Tull J; Ghilezan M; Krauss D; Balaraman S; Kernen K; Cotant M; Margolis J; Vicini FA
    Am J Clin Oncol; 2013 Apr; 36(2):121-5. PubMed ID: 22307214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of prostate cancer in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013.
    Williams S; Chiong E; Lojanapiwat B; Umbas R; Akaza H;
    Lancet Oncol; 2013 Nov; 14(12):e524-34. PubMed ID: 24176571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for prostate cancer: the current evidence and guidelines controversy.
    Gomella LG; Liu XS; Trabulsi EJ; Kelly WK; Myers R; Showalter T; Dicker A; Wender R
    Can J Urol; 2011 Oct; 18(5):5875-83. PubMed ID: 22018148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update of the NCCN guidelines for treatment of prostate cancer.
    Millikan R; Logothetis C
    Oncology (Williston Park); 1997 Nov; 11(11A):180-93. PubMed ID: 9430189
    [No Abstract]   [Full Text] [Related]  

  • 12. Kidney Cancer Working Group report.
    Naito S; Tomita Y; Rha SY; Uemura H; Oya M; Song HZ; Zhong LH; Wahid MI
    Jpn J Clin Oncol; 2010 Sep; 40 Suppl 1():i51-56. PubMed ID: 20870920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prostate cancer: interpretation of management guidelines].
    Ploussard G; Desgrandchamps F
    Rev Prat; 2013 Apr; 63(4):515-20. PubMed ID: 23682482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NCCN Prostate Cancer Practice Guidelines. The National Comprehensive Cancer Network.
    Baker LH; Hanks G; Gershenson D; Kantoff P; Lange P; Logothetis C; Sandler H; Walsh P
    Oncology (Williston Park); 1996 Nov; 10(11 Suppl):265-88. PubMed ID: 8953609
    [No Abstract]   [Full Text] [Related]  

  • 15. Active surveillance monitoring more stringent in updated NCCN Guidelines for prostate cancer.
    J Natl Compr Canc Netw; 2011 May; 9(5):xxxvii-xlii. PubMed ID: 21739727
    [No Abstract]   [Full Text] [Related]  

  • 16. Update: NCCN prostate cancer Clinical Practice Guidelines.
    Scardino P
    J Natl Compr Canc Netw; 2005 Nov; 3 Suppl 1():S29-33. PubMed ID: 16280109
    [No Abstract]   [Full Text] [Related]  

  • 17. [Management of prostate cancer biochemical recurrence in the clinical guidelines].
    Fernández CH; Patiño GE; Merino RD; Chomón GB; Rios DS; Gárate MM; Gil MJ
    Arch Esp Urol; 2012; 65(1):79-83. PubMed ID: 22318179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Institutional validation of breast cancer treatment guidelines.
    Minter RM; Spengler KK; Topping DP; Flug R; Copeland EM; Lind DS
    J Surg Res; 2001 Sep; 100(1):106-9. PubMed ID: 11516212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The NCCN guideline program--1998.
    Winn RJ; Botnick WZ; Brown NH
    Oncology (Williston Park); 1998 Nov; 12(11A):30-4. PubMed ID: 10028501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of kidney cancer in Asia: resource-stratified guidelines from the Asian Oncology Summit 2012.
    Chiong E; Tay MH; Tan MH; Kumar S; Sim HG; Teh BT; Umbas R; Chau NM
    Lancet Oncol; 2012 Nov; 13(11):e482-91. PubMed ID: 23117003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.